| 11th Sep 2024 7:00 am |
RNS |
Cancellation - BiVictriX Therapeutics plc |
| 10th Sep 2024 11:04 am |
RNS |
Holding(s) in Company |
| 10th Sep 2024 7:00 am |
RNS |
Last Day of Dealings |
| 9th Sep 2024 7:00 am |
RNS |
Positive In Vivo Data from BVX002 Programme |
| 2nd Sep 2024 5:04 pm |
RNS |
Holding(s) in Company |
| 2nd Sep 2024 8:50 am |
RNS |
Director Dealing |
| 29th Aug 2024 5:05 pm |
RNS |
Result of General Meeting |
| 28th Aug 2024 10:14 am |
RNS |
Holding(s) in Company |
| 28th Aug 2024 10:12 am |
RNS |
Holding(s) in Company |
| 19th Aug 2024 7:00 am |
RNS |
TR-1: Notification of major holdings |
| 13th Aug 2024 7:00 am |
RNS |
Grant of Options |
| 12th Aug 2024 7:00 am |
RNS |
Proposed Voluntary Delisting |
| 1st Aug 2024 7:00 am |
RNS |
Interim Results |
| 24th Jul 2024 5:00 pm |
RNS |
Result of Annual General Meeting |
| 26th Jun 2024 7:00 am |
RNS |
Publication of 2023 Annual Report & Notice of AGM |
| 13th Jun 2024 7:00 am |
RNS |
Compelling Safety Profile of BVX001 |
| 6th Jun 2024 7:00 am |
RNS |
Innovate UK Grant Award to Accelerate ADC Pipeline |
| 31st May 2024 8:44 am |
RNS |
BiVictriX – Full Year Results 2023 |
| 17th Apr 2024 7:00 am |
RNS |
Orphan Drug Designation & FDA INTERACT Meeting |
| 28th Mar 2024 7:00 am |
RNS |
Grant of Options – PDMR/Director Dealings |
| 4th Jan 2024 12:30 pm |
RNS |
Holding(s) in Company |
| 4th Jan 2024 12:30 pm |
RNS |
Holding(s) in Company |
| 4th Jan 2024 7:00 am |
RNS |
BiVictriX Hosts Inaugural Roundtable Discussion |
| 5th Dec 2023 11:08 am |
RNS |
Board Change |
| 30th Nov 2023 7:00 am |
RNS |
Pipeline update on BVX002 |
| 22nd Nov 2023 5:14 pm |
RNS |
Holding(s) in Company |
| 15th Nov 2023 7:00 am |
RNS |
Patent Granted in Japan |
| 12th Oct 2023 7:00 am |
RNS |
Extended Survival Rates Reported with BVX001 |
| 3rd Oct 2023 7:00 am |
RNS |
Appointment of Adrian Howd as CFO and CBO |
| 19th Sep 2023 7:00 am |
RNS |
Interim Results |
| 31st Aug 2023 7:00 am |
RNS |
Total Voting Rights |
| 23rd Aug 2023 7:00 am |
RNS |
US Patent Granted |
| 17th Aug 2023 7:00 am |
RNS |
Holding(s) in Company |
| 16th Aug 2023 6:00 pm |
RNS |
Holding(s) in Company |
| 11th Aug 2023 4:17 pm |
RNS |
Holding(s) in Company |
| 8th Aug 2023 5:18 pm |
RNS |
Result of General Meeting |
| 19th Jul 2023 6:16 pm |
RNS |
Result of Conditional Fundraise |
| 19th Jul 2023 12:31 pm |
RNS |
Proposed Fundraise in excess of £2 million |
| 17th Jul 2023 7:00 am |
RNS |
Positive final data in preclinical efficacy study |
| 19th Jun 2023 7:00 am |
RNS |
Positive interim data |
